ASX Share rice
Wed 12 Aug 2020 - 10:58:am (Sydney)

GSS Share Price

GENETIC SIGNATURES LIMITEDGSSPharmaceuticals, Biotechnology & Life Sciences

GSS Company Information


Genetic Signatures Limited




Medical Laboratories & Research

GIC Industry:

Life Sciences Tools & Services

GIC Sub Industry:

Life Sciences Tools & Services


7 Eliza Street Sydney NSW Australia 2042


61 2 9870 7580

MD, CEO & Exec. Director:

Dr. John R. Melki

CFO & Company Sec.:

Mr. Peter Manley

Exec. Director of US Operations & Exec. Director:

Mr. Michael Anton Aicher M.B.A., BSc, MBA

Founder & Chairman Emeritus:

Mr. Christopher M. Abbott

Chief Scientific Officer:

Dr. Douglas S. Millar BSc, Ph.D.

Company Overview:

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in North America and Australia. The company designs and manufactures a suite of real-time polymerase chain reaction based products for detection of infectious diseases under EasyScreen brand name. It also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, the company offers MethylEasy for DNA bisulphite modification of histones for screening of cancer and embryonic development, as well as use in stem cell technologies. Genetic Signatures Limited was founded in 2001 and is headquartered in Sydney, Australia.

GSS Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Profit Margin:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


GSS CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Income:


Total Cash From Operating Activities:




Change To Inventory:


Change To Account Receivables:


Sale Purchase Of Stock:


Capital Expenditures:


GSS Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Other Operating Expenses:


Interest Expense:


Total Revenue:


Total Operating Expenses:


Cost Of Revenue:


GSS Balance Sheet

Balance Sheet Date:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Other Current Assets:


Retained Earnings:


Other Liabilities:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Total Current Assets:


Net Receivables:


Short-Term Investments:




Accounts Payable:


Non Currrent Assets (Other):


Short-Term Investments:


Non Current Liabilities Total:


GSS Share Price History

GSS News

31 Jul, 2020
Genetic Signatures Limited (ASX:GSS) shareholders will have a reason to smile today, with the covering analyst making...
08 May, 2020
Celebrations may be in order for Genetic Signatures Limited (ASX:GSS) shareholders, with the covering analyst...
20 Apr, 2020
For many, the main point of investing in the stock market is to achieve spectacular returns. While not every stock...
21 Feb, 2020
John Melki has been the CEO of Genetic Signatures Limited (ASX:GSS) since 2011. First, this article will compare CEO...
23 Dec, 2019
Genetic Signatures Limited's (ASX:GSS): Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in...
23 Oct, 2019
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But in contrast you can...
23 Sep, 2019
Just because a business does not make any money, does not mean that the stock will go down. For example, although...